This report examines how amendment drivers vary across therapeutic areas and how those changes impact execution, patient burden, site workload, timelines, and study costs.

Confidential disclosure agreements (CDAs) can cause clinical trial delays, but streamlining negotiations reduces friction and improves efficiency, fostering better long-term relationships between sponsors and sites.

By following this checklist, research teams can enhance organizational efficiency, maintain compliance with regulatory standards, and confidently navigate the complexities of documentation management.

How can effective hazard communication and SOPs from institutional biosafety committees enhance safety in clinical trials involving rDNA technologies and genetically modified biological agents?

Delve into the importance of training and educating research staff on the sIRB process, fostering a culture of collaboration, and developing mechanisms for monitoring compliance and managing conflicts.

What role does Good Clinical Practice (GCP) play in the clinical research ecosystem and how does it safeguard participant rights, safety, and confidentiality while fostering compliance?

This overview highlights real research programs at various stages of the recruitment process and demonstrates the impact of Advarra’s Longboat Platform across multiple therapeutic areas and sponsors.

By bringing objective evaluation, expertise, and effective change management skills, learn how interim staff can improve an institution’s ability to identify issues and implement necessary changes.

With technology advancing clinical operations, proactive adaptation is paramount for organizations to remain at the forefront. How can your organization effectively navigate these evolving dynamics?

With Longboat, this pharma company trained all staff across trial sites, ensuring treatment for all 20,000 patients with real-time training reports.

Uncover how a biotechnology company experienced recruitment and compliance success after utilizing Longboat to provide training for every staff member at every trial site.

Reporting noncompliance concerns is crucial to protect research participants, allowing researchers can ensure ethical research conduct and protect the rights and welfare of participants.

Discover the strategic benefits of deploying consistent Data Safety Monitoring Boards (DSMBs) members across therapeutic programs.

Uncover key survey findings gleaned from the perspectives of over 500 clinical researchers regarding technological trends and recommendations for enhancing the overall site experience.

Experts discuss how to navigate the complexities of adaptive trial designs and how ethics reviews uphold patient safety, ensure informed consent, and provide robust oversight.